4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-004562
Chief Patient Supply Officer sold 22,795 shares at an average $0.70 ($15,889)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lunger John Chief Patient Supply Officer | 2024-01-16 | Sale | −4,681 | $0.79 | $3,698 | 7,023 | D |
| Lunger John Chief Patient Supply Officer | 2024-01-17 | Sale | −5,309 | $0.67 | $3,573 | 7,785 | D |
| Lunger John Chief Patient Supply Officer | 2024-01-17 | Sale | −12,805 | $0.67 | $8,618 | 19,015 | D |
| Open-market sales · 22,795 sh · avg $0.70 · $15,889 | |||||||
Loading xslF345X05/tm243270-14_4seq1.xml…